Statewide

Nebraska Medicine Division of Prehospital and Emergency Medical Services

Current186 dose entries52 drugs5 documentsNEeffective 2026-05-0195% machine-parsed of 186

Nebraska Medicine Division of Prehospital and Emergency Medical Services (NE) carries 52 drugs across 186 dose entries in its current published protocol, effective 2026-05-01.

Drugs and doses52

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	325–1000 mg	PO	not captured	standing	pages 25, 87
Mild to moderate pain	adult	650–1000 mg	IV/IO	not captured	standing	pages 25, 87
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 25, 87
Mild to moderate pain	peds	15 mg/kg	IV/IO	not captured	standing	pages 25, 87

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 65, 111, 170
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 65, 111, 170

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	150 mg	IV/IO	not captured	standing	page 39
Wide-complex tachycardia	adult	300 mg	IV/IO	not captured	standing	pages 31, 91
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 31, 91
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 31, 91
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 31, 91

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	324 mg	PO	not captured	standing	pages 43, 172

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 41, 99, 173
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 41, 99, 173
Nerve agent exposure	adult	2 mg	IV/IO/IM	not captured	standing	pages 151, 173
Nerve agent exposure	peds	0.05 mg/kg	IV/IO/IM	not captured	standing	pages 151, 173
Organophosphate poisoning	adult	2 mg	IV/IO	not captured	standing	pages 151, 173
Organophosphate poisoning	peds	0.05 mg/kg	IV/IO	not captured	standing	pages 151, 173

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1000 mg	IV/IO	not captured	standing	pages 109, 125
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 109, 125
Hyperkalemia	adult	1000 mg	IV/IO	not captured	standing	page 174
Other	adult	1000 mg	IV/IO	not captured	standing	page 174
Other	adult	1000 mg	IV/IO	not captured	standing	page 174

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV/IO	not captured	standing	pages 125, 175
Beta-blocker / calcium-channel-blocker overdose	peds	20 mg/kg	IV/IO	not captured	standing	pages 125, 175
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 31, 33, 125, 175
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 31, 33, 125, 175

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	peds	0.6 mg/kg	IV/IO	not captured	standing	pages 49, 101
Other	peds	0.6 mg/kg	IV/IO	not captured	standing	pages 49, 101

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	page 176
Hypoglycemia	peds	0.5 g/kg	IV/IO	not captured	standing	page 176

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	adult	2 mg	IV/IO	not captured	standing	pages 67, 113, 178
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 67, 113, 178
Seizure	peds	0.2 mg/kg	PR	not captured	standing	page 178

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	0.25 mg/kg	IV/IO	not captured	standing	pages 37, 179

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IO	not captured	standing	pages 49, 101
Allergic reaction	peds	1 mg/kg	IV/IO	not captured	standing	pages 49, 101
Dystonic reaction	adult	50 mg	IV/IO/IM	not captured	standing	pages 12, 71
Dystonic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 12, 71
Other	adult	25 mg	IV	not captured	standing	page 11
Other	adult	50 mg	IM	not captured	standing	page 11

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 181
Bradycardia	peds	5–20 mcg/kg	IV/IO	not captured	standing	page 181
Other	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 181
Other	peds	5–20 mcg/kg	IV/IO	not captured	standing	page 181

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5–5 mg	IV	not captured	standing	page 11
Other	adult	5–10 mg	IM	not captured	standing	page 11

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 49, 101, 183
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 49, 101, 183
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	page 183
Asthma / bronchospasm	peds	0.15 mg	IM	not captured	standing	page 183
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 31, 33, 89, 91, 93, 184
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 31, 33, 89, 91, 93, 184

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	pages 83, 186
RSI induction	peds	0.3 mg/kg	IV/IO	not captured	standing	pages 83, 186

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 87
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 87
Procedural sedation	adult	1 mcg/kg	IV/IO	not captured	standing	pages 23, 85
Procedural sedation	peds	1 mcg/kg	IV/IO	not captured	standing	pages 23, 85

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV/IO	not captured	standing	page 188
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV/IO	not captured	standing	page 188
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg	IV/IO	not captured	standing	page 188
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg	IV/IO	not captured	standing	page 188
Hypoglycemia	adult	1 mg	IM/SQ	not captured	standing	page 188
Hypoglycemia	adult	3 mg	IN	not captured	standing	page 188
Hypoglycemia	peds	0.1 mg/kg	IM/SQ	not captured	standing	page 188

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5–5 mg	IV	not captured	standing	page 11
Other	adult	5–10 mg	IM	not captured	standing	page 11

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.5–1 mg	IV/IO/IM/IN	not captured	standing	pages 25, 87
Mild to moderate pain	peds	0.01 mg/kg	IV/IO/IM/IN	not captured	standing	pages 25, 87
Procedural sedation	adult	0.5–1 mg	IV/IO	not captured	standing	pages 23, 85
Procedural sedation	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 23, 85

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	page 190
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	page 190
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	page 190
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	page 190

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	400–800 mg	PO	not captured	standing	pages 25, 87
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	pages 25, 87

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 65, 111, 192
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 65, 111, 192

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mg/kg	IV/IO	not captured	standing	pages 23, 85
Other	adult	3 mg/kg	IV/IO	not captured	standing	pages 21, 83
Other	adult	3–5 mg/kg	IM	not captured	standing	page 11
Other	peds	0.5 mg/kg	IV/IO	not captured	standing	pages 23, 85
Other	peds	2–3 mg/kg	IV/IO	not captured	standing	pages 21, 83

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV/IO	not captured	standing	pages 25, 87
Mild to moderate pain	adult	30 mg	IM	not captured	standing	pages 25, 87

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10–20 mg	IV	not captured	standing	page 195

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	40 mg	IO	not captured	standing	page 196
Other	peds	0.5 mg/kg	IO	not captured	standing	page 196
Wide-complex tachycardia	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 31, 91
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	pages 31, 91
VF / pulseless VT	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 31, 91
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 31, 91

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1–2 mg	IV/IO	not captured	standing	page 11
Other	adult	2 mg	IV/IO	not captured	standing	page 11
Procedural sedation	adult	1–2 mg	IV/IO/IN	not captured	standing	page 25
Seizure	adult	2 mg	IV/IO	not captured	standing	pages 67, 113
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 67, 113

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	peds	2 g	IV/IO	not captured	standing	pages 65, 111
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 198
Other	adult	2 g	IV/IO	not captured	standing	page 12
Tricyclic overdose	peds	2 g	IV/IO	not captured	standing	pages 63, 109
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	pages 31, 39, 91, 97
VF / pulseless VT	peds	40 mg/kg	IV/IO	not captured	standing	pages 31, 39, 91, 97

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	125 mg	IV/IO	not captured	standing	pages 49, 101
Allergic reaction	peds	1 mg/kg	IV/IO	not captured	standing	pages 49, 101
Other	adult	125 mg	IV/IO	not captured	standing	pages 49, 65, 101, 111
Other	adult	125 mg	IV/IO	not captured	standing	page 199
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 49, 65, 101, 111
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 199

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM	not captured	standing	pages 71, 115, 200
Nausea / vomiting	peds	0.1–0.2 mg/kg	IV/IM	not captured	standing	pages 71, 115, 200
Other	adult	5–10 mg	IV/IM	not captured	standing	page 200
Other	peds	0.1–0.2 mg/kg	IV/IM	not captured	standing	page 200

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	2.5–5 mg	IV/IO	not captured	standing	pages 37, 201

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.05 mg/kg	IV/IO/IM/IN	not captured	standing	pages 23, 85
Other	adult	1–2 mg	IV/IO/IN	not captured	standing	page 202
Other	adult	2 mg	IV	not captured	standing	page 11
Other	adult	5 mg	IM	not captured	standing	page 11
Other	adult	5–10 mg	IV/IO/IN	not captured	standing	page 202
Other	peds	0.05 mg/kg	IV/IO/IM/IN	not captured	standing	pages 23, 85
Other	peds	0.05 mg/kg	IV/IO/IN	not captured	standing	page 202
Procedural sedation	adult	2 mg	IV/IO/IM/IN	not captured	standing	pages 37, 39, 41, 97, 99
Procedural sedation	peds	0.1–0.2 mg/kg	IV/IO/IM/IN	not captured	standing	pages 37, 39, 41, 97, 99
Seizure	adult	2 mg	IV/IO	not captured	standing	pages 67, 85
Seizure	adult	5 mg	IM/IN	not captured	standing	pages 67, 113
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 67, 85
Seizure	peds	0.2 mg/kg	IM/IN	not captured	standing	pages 67, 113

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 25, 87
Mild to moderate pain	peds	0.05 mg/kg	IV/IO/IM	not captured	standing	pages 25, 87
Procedural sedation	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 23, 85
Procedural sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 23, 85

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1 mg/kg	IN	not captured	standing	page 25
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	page 25
Other	peds	0.1 mg/kg	IN	not captured	standing	page 25
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 25
Respiratory distress	peds	0.1 mg (max 2 mg)	IM/IN	not captured	standing	page 204
Respiratory distress	peds	0.1 mg (max 2 mg)	IV/IO	not captured	standing	page 204

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	2 kits	IM	not captured	standing	page 182
Seizure	adult	3 kits	IM	not captured	standing	page 182

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 205
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 205
Other	adult	0.4 mg	SL	not captured	standing	page 205

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	4–30 mcg	IV/IO	not captured	standing	page 206
Hypotension / shock	peds	0.05–0.1 mcg/kg	IV/IO	not captured	standing	page 206

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IO/IM/PO	not captured	standing	pages 71, 115, 207
Nausea / vomiting	peds	0.15 mg/kg	IV/IO/IM/PO	not captured	standing	pages 71, 115, 207

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15–31 g	PO	not captured	standing	page 177
Hypoglycemia	peds	7.5–15.5 g	PO	not captured	standing	page 177

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	pages 151, 152, 182

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM	not captured	standing	pages 71, 115, 209
Nausea / vomiting	peds	0.1–0.15 mg/kg	IV/IM	not captured	standing	pages 71, 115, 209
Other	adult	5–10 mg	IV/IM	not captured	standing	page 209
Other	peds	0.1–0.15 mg/kg	IV/IM	not captured	standing	page 209

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5–25 mg	IV/IO/IM/PO	not captured	standing	pages 115, 210
Nausea / vomiting	peds	0.25–1 mg/kg	IV/IO/IM/PO	not captured	standing	pages 115, 210

Proparacaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	1–2 drop	not captured	not captured	standing	page 211
Burns	peds	1–2 drop	not captured	not captured	standing	page 211
Other	adult	1–2 drop	not captured	not captured	standing	page 211
Other	adult	1–2 drop	not captured	not captured	standing	page 211
Other	peds	1–2 drop	not captured	not captured	standing	page 211
Other	peds	1–2 drop	not captured	not captured	standing	page 211

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	page 212
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	page 212

Rectal Valium

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	peds	0.3 mg/kg	PR	not captured	standing	page 113

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	IV/IO	not captured	standing	pages 23, 85
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 23, 85
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	page 21
RSI induction	peds	1 mg/kg	IV/IO	not captured	standing	page 21

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	100 mEq	IV/IO	not captured	standing	page 125
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	page 125
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	pages 31, 33, 93
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 31, 33, 93
Other	adult	100 mEq	IV/IO	not captured	standing	page 11
Tricyclic overdose	adult	100 mEq	IV/IO	not captured	standing	pages 63, 109
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	pages 63, 109

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 83, 215
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 83, 215

Tetracaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	2 drop	not captured	not captured	standing	page 127
Mild to moderate pain	peds	2 drop	not captured	not captured	standing	page 127

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV	not captured	standing	pages 117, 216

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 23, 85
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 23, 85
RSI induction	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 21, 83
RSI induction	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 21, 83

Cite this

Nebraska Medicine Division of Prehospital and Emergency Medical Services, United States EMS Protocol Census. 186 dose entries, effective 2026-05-01.

https://protoquiz.com/census/agencies/nebraska-medicine-division-of-prehospital-and-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.